The portfolio company CMA Microdialysis restructures operations

7/4/2011 8:00 AM EST

Bure Equity’s portfolio company CMA Microdialysis sells its preclinical business and its subsidiary Dilab. CMA Microdialysis continuing operations will be renamed to Dipolyn Medical AB.

For more information see enclosed press releases and Dipylon Medicals web page: www.dipylonmedical.com

For more information contact:
Patrik Tigerschiöld, CEO
Tel. +46 8 614 00 20

Bure Equity

RSS

Bure is a growth- and knowledge company within private equity. We invest preferable in unlisted companies within IT, infomedia and education.

CONTACT

Bure Equity
+46-(0)31-708 64 00
http://www.bure.se

Andreas Berglin
CFO
+46 (0) 8 – 614 00 20
http://www.bure.se

Recent Releases

Bure invests in Rushrail and acquires state-of-the-art locomotives
5/8/2012 3:00 AM EST
Bure sells holdings in Carnegie Holding, Carnegie Asset Management and Max Matthiessen.
5/2/2012 2:00 AM EST
2012 Annual General Meeting of Bure equity AB
4/26/2012 3:00 AM EST
NOTICE OF ANNUAL GENERAL MEETING
3/15/2012 6:49 AM EST
Interim report January – September 2011
11/15/2011 3:30 AM EST

The portfolio company CMA Microdialysis restructures operations

Bure Equity

Related documents

Recent Releases